A single infusion of phospholipid liposomes promptly and persistently abolished the ability of hypercholesterolemic rabbit plasma to cause cholesteryl ester loading in cultured macrophages. This phospholipid enrichment of plasma caused moderate stimulation of cellular cholesterol efflux and, unexpectedly, almost complete inhibition of cellular uptake of 13-very low density lipoprotein (8-VLDL), the major cholesteryl ester-rich particle in hypercholesterolemic rabbit plasma. Cell viability and LDL receptor activity were unaffected. Incubation of liposomes with fl-VLDL resulted in transfer of apolipoprotein-E (apoE) to the liposomes; reisolated apoE-phospholipid liposomes then competed efficiently for cellular apoprotein receptors. Thus, a major mechanism by which phospholipid infusions result in diminished accumulation of cholesteryl ester in cultured macrophages is by blocking cellular uptake of 1-VLDL. The liposomes deplete fl-VLDL of apoE, then compete for receptor-mediated uptake. These results suggest a novel mechanism contributing to the known antiatherogenic effect of phospholipid infusions: infused liposomes acquire apoE, then block uptake of atherogenic lipoproteins by arterial wall macrophages.
Introduction
Cholesterol-fed rabbits develop deposits of cholesterol in their arterial walls and have been used extensively as an experimental model ofatherosclerosis. The deposits of cholesterol result from uptake by vessel wall macrophages of 3-very low density lipoprotein (fl-VLDL), the major cholesteryl ester-rich lipoprotein in the plasma of cholesterol-fed rabbits (1) . Macrophage uptake of f3-VLDL is mediated by a cell surface receptor that is immunologically identical to the LDL receptor but displays different functional properties (2) .
Three decades ago, repeated intravenous administration of dispersed phospholipid was shown to produce rapid, substantial shrinkage of atherosclerotic deposits in cholesterol-fed rabbits (3) . This result has been confirmed by several laboratories using a variety of animal models (4-1 1). Phospholipid infusions have recently been shown to result in the appearance of vesicular lipoproteins in plasma (12) . The vesicular lipoproteins remove cholesterol from other lipoproteins and from tissues (12) and they acquire apolipoprotein (apo) E' and bind to LDL receptors (13) . These observations support the hypothesis that the antiatherogenic effect of phospholipid infusions results in part from uptake oftissue cholesterol by vesicular lipoproteins, with reverse cholesterol transport to the liver mediated perhaps by hepatic apolipoprotein receptors (1 1) .
The most striking examples of phospholipid-induced regression of experimental atherosclerosis were those in which regression was shown to occur even while the animals were maintained on the high cholesterol diets (9, 10) . Thus, the phospholipid infusions converted highly atherogenic plasma into antiatherogenic plasma. Using cultured macrophages as a model of the macrophages in the arterial wall, we investigated the effect of phospholipid infusions on the ability of hypercholesterolemic rabbit plasma to cause cellular cholesterol loading and efflux.
We found that phospholipid enrichment of plasma produced a moderate enhancement of cellular cholesterol efflux in vitro. However, added phospholipid liposomes unexpectedly produced a dramatic inhibition in cellular uptake of the atherogenic 13-VLDL particles.
A preliminary report of this work was presented at the 59th Scientific Sessions of the American Heart Association (14) .
Methods
Lipoproteins and liposomes. Rabbit #l-VLDL (d < 1.006 g/ml) was prepared by ultracentrifugation of hypercholesterolemic rabbit plasma. Human LDL (d = 1.0 19-1.063 g/ml) was prepared by ultracentrifugation of fresh human plasma (15). Acetyl-LDL was prepared by reaction with acetic anhydride (16) .
Radioiodinated fl-VLDL and LDL were prepared by a modification of the iodine monochloride method (17) . By dodecyl sulfate-polyacrylamide gel electrophoresis ( 18) of the 125I-f-VLDL, 71.0% of recovered radioactivity was in apoB, 6.6% was in apoE, 4.5% in apoA-I, and 6.0% in C-apoproteins. [7-3H] Cholesteryl ester-labeled f3-VLDL, LDL, and acetyl-LDL were prepared by incubation with labeled HDL (19) and cholesteryl ester transfer protein, followed by ultracentrifugal reisolation of the less dense lipoproteins. By silica-gel thin-layer chromatography (20) (25) , and the resident mouse peritoneal macrophage, which accumulates cholesteryl ester when incubated with fl-VLDL or acetyl-LDL (1, 26) . Monolayer cultures of the J774 macrophages were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (vol/vol) fetal calf serum (FCS). Resident mouse peritoneal macrophages were prepared as needed by cold saline irrigation of the peritoneal cavities of sacrificed mice. Macrophages were separated from other peritoneal cells by their ability to adhere firmly to plastic wells during a 2-h incubation at 370C (27 To assess the ability of pre-and postinfusion hypercholesterolemic rabbit plasma to cause cellular cholesterol loading and cholesterol efflux, the labeled J774 cells were incubated for 18 h in DMEM supplemented with fatty acid-free bovine serum albumin (fBSA) (control medium) or in control medium supplemented with 10% (vol/vol) pre-or postinfusion hypercholesterolemic rabbit plasma. Additional wells of labeled cells were incubated in control medium supplemented with preinfusion plasma plus 0.6 mg liposomal phospholipid/ml, or with liposomes without plasma.
Cells were then scraped into the media, and media and cells were separated by low-speed centrifugation. Cells were resuspended in buffer and repelleted three times to remove any residual media. Cells and media were separately counted for 3H-radioactivity; the percentage of total radioactivity (i.e., in cells plus media) remaining in the cells was computed for each well. Cells were assayed for protein by the method of Lowry et al. (28) and for total and unesterified cholesterol by gas-liquid chromatography using ,B-sitosterol as an internal standard (23) . Cholesteryl ester content was calculated as the difference between total and unesterified cholesterol. Cholesterol values were normalized for cellular protein content. Cellular viabilities were determined by trypan blue exclusion (29) .
Analogous experiments were performed with mouse peritoneal macrophages. Mouse peritoneal macrophages were loaded with [3H]cholesterol by a 2.5-h incubation in [(7-3H)cholesteryl ester]-acetyl-LDL (10 sg protein/ml). These labeled macrophages were then incubated in DMEM/0. 1% fBSA without supplementation (control) or in control medium supplemented with ,B-VLDL alone or with fl-VLDL and added liposomes. Cellular cholesterol masses, viabilities, retained 3H radioactivity were measured as described above.
Direct measurement ofcellular uptake and degradation of fl-VLDL. '25I-,-VLDL was incubated with J774 or mouse peritoneal macrophages in DMEM with or without plasma, and with or without added liposomes.
Cell association of '25I-3-VLDL was determined by measuring cellular 1251-radioactivity (30) . Degradation of '25I-fl-VLDL was determined by measuring the release of tnichloroacetic acid-soluble, chloroform-insoluble '251-radioactivity into the media. Cell-specific degradation was calculated by subtracting spontaneous degradation measured in cell-free wells from the total degradation measured in the presence ofcells (30) . Spontaneous degradation was at most 3.2 ng '25I-,6-VLDL protein per 35-mm tissue culture well. These cell-association and degradation data reflect primarily the catabolism of apoB, which contained most of the radioactivity in the '251-f-VLDL. Cell association was determined for [(7-3H)cholesteryl ester]-,-VLDL by measuring cellular 3H radioactivity.
Reisolation ofliposomes and -VLDL after coincubation. Unlabeled ,B-VLDL was dialyzed against 50 mM sodium phosphate buffer, pH 7.4. Phosphatidylcholine liposomes were prepared by sonication in 50 mM sodium phosphate buffer. creased the cellular contents of total cholesterol and cholesteryl ester to approximately twice the control values (Fig. 1 ). In contrast, incubation with postinfusion plasma from the same rabbit resulted in essentially no net cellular accumulation of either total cholesterol or cholesteryl ester compared to control (Fig. 1) . Performing this experiment with a range of cholesterol contents in the preloaded, control cells (101.2, 153.4, and 181.3 nmol total cholesterol/mg protein) and a range of cholesterol concentrations in the preinfusion, hypercholesterolemic plasma (7.3, 9.8, and 1.5 mmol/liter) produced the same results: preinfusion plasmas consistently caused large increases in total cellular cholesterol and cholesteryl ester over control, whereas postinfusion plasmas resulted in total cholesterol and cholesteryl ester contents nearly identical to control (not displayed). Thus, although the preinfusion, hypercholesterolemic rabbit plasmas were extremely potent in cholesterol-loading the cells, plasmas obtained from the same rabbits 20 min after a phospholipid infusion were nearly inert.
Despite the large difference in cellular cholesterol content between J774 cells incubated with pre-and postinfusion hypercholesterolemic plasma, a comparatively small difference was observed in the amount of cholesterol radioactivity retained by these cells (Fig. 1, hatched bars) . The cells retained 19% less total cholesterol radioactivity in postinfusion plasma than in preinfusion plasma, but the total cholesterol mass was 44% less. Phospholipid-enrichment ofhypercholesterolemic plasma in vivo by infusion or in vitro by adding liposomes to preinfusion plasma produced nearly identical effects on cellular cholesterol mass and radioactivity (Fig. 1) . Phospholipid liposomes without plasma produced parallel losses of cholesterol mass and radioactivity (Fig. 1) .
Similar impairment of cholesterol loading was seen with mouse peritoneal macrophages. Modification by liposomes of cellular uptake of 3-VLDL. The contrasting effects on cholesterol mass and retained cholesterol radioactivity in J774 and mouse peritoneal macrophages strongly suggest that decreased accumulation of cellular cholesterol in the presence ofliposomes does not primarily result from enhanced cholesterol efflux, but is rather the result of decreased uptake of ,B-VLDL cholesterol from the media. To measure directly the cellular uptake ofB-VLDL from pre-and postinfusion plasma, J774 macrophages were incubated for 5 The reduction in cell-association and degradation of 125I-,B-VLDL also occurred when sonicated phospholipid was added to isolated '25I-fl-VLDL in the absence of plasma. In dose-response experiments, there was a progressive decrease in cellassociation (not displayed) and degradation (Fig. 2) (Fig. 4) , and the low contents of cholesteryl ester (c 0.6 mass% in these preparations). Both vesicles I and II acquired unesterified cholesterol from 3-VLDL. In addition, both preparations acquired protein from f3-VLDL, although the mass ratio of protein to phospholipid in vesicles II was approximately six times the ratio in vesicles I. Because the predominant protein in both preparations was apoE (Fig. 4) , the higher mass ratio of protein to phospholipid in vesicles II indicates a higher apoE content.
In competitive displacement studies, vesicles I and II showed potent receptor binding, whereas protein-free phospholipid liposomes had little effect (Fig. 5 A) . Of the two preparations of reisolated vesicles, vesicles II showed greater receptor affinity (Fig. 5 A) , consistent with its greater apoE content. Time course of the cholesterol-loading ability of hypercholesteremic rabbit plasmafollowing an infusion ofliposomes. For these observations to have relevance to atherosclerosis, infused liposomes must produce sustained alterations in the cholesterolloading ability of hypercholesterolemic rabbit plasma. We therefore examined the cholesterol-loading abilities of plasma samples obtained before and up to 24 h after a single infusion of phospholipid liposomes. After the infusion, plasma phospholipid concentration rose, declined rapidly in the first hour, then declined more gradually from 1 to 24 h (Fig. 6 A) . The gradual disappearance of excess phospholipid from the circulation is consistent with prior reports of prolonged half-lives for cholesterol-free liposomes infused in large doses (> 25-100 mg/kg body weight) (1 1, 12, 33, 34) . Following the infusion, the plasma concentration of unesterified cholesterol initially fell. This fall was seen in all phospholipid-infused, hypercholesterolemic rabbits, and coincided with the initial, rapid clearance of phospholipid. From 20 min to 24 h after the phospholipid infusion, the plasma concentration of unesterified cholesterol steadily rose (Fig. 6 A) , consistent with the findings of previous studies (3, 5, 11, 12, (35) (36) (37) (38) . Plasma cholesteryl ester concentration rose slightly following the infusion and returned to the preinfusion value by 24 h (Fig. 6 A) .
Impairment of the ability of hypercholesterolemic plasma to cause cholesterol accumulation in cultured macrophages lasted for hours following a phospholipid infusion (Fig. 6 B) . Plasma obtained 4 h after a phospholipid bolus behaved identically to plasma obtained 20 min after the bolus. By Phospholipid liposomes also inhibit cholesterol-loading of cultured macrophages by plasma rich in LDL, the major atherogenic lipoprotein in many types ofhuman plasma. Incubation of J774 macrophages with LDL-rich plasma from a Watanabe Heritable Hyperlipidemic rabbit (26) increased cellular total and esterified cholesterol contents to 346% and 718% of control, respectively. Incubation with plasma plus 1.2 mg sonicated egg phosphatidylcholine/ml medium resulted in total and esterified cholesterol contents that were only 131 and 154% of control (Williams, K. J., T. Donnelly, T. Parker, and A. R. Tall, unpublished data). As a general concept, phospholipid-rich, cholesterol-poor particles, such as vesicular lipoproteins or phospholipid-enriched HDL, may acquire apoE in atherogenic plasma, then compete with atherogenic particles for receptormediated uptake by foam cells.
